GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Research Alliance Corp II (NAS:RACB) » Definitions » COGS-to-Revenue

Research Alliance II (Research Alliance II) COGS-to-Revenue : 0.00 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Research Alliance II COGS-to-Revenue?

Research Alliance II's Cost of Goods Sold for the three months ended in Sep. 2022 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2022 was $0.00 Mil.

Research Alliance II's COGS to Revenue for the three months ended in Sep. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Research Alliance II's Gross Margin % for the three months ended in Sep. 2022 was N/A%.

Research Alliance II COGS-to-Revenue Historical Data

The historical data trend for Research Alliance II's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Research Alliance II COGS-to-Revenue Chart

Research Alliance II Annual Data
Trend Dec20 Dec21
COGS-to-Revenue
- -

Research Alliance II Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
COGS-to-Revenue Get a 7-Day Free Trial - - - - -

Research Alliance II COGS-to-Revenue Calculation

Research Alliance II's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Research Alliance II's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Research Alliance II  (NAS:RACB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Research Alliance II's Gross Margin % for the three months ended in Sep. 2022 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Research Alliance II COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Research Alliance II's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Research Alliance II (Research Alliance II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Research Alliance Corp II (NAS:RACB) » Definitions » COGS-to-Revenue
Comparable Companies
BLSA ARYD MITA OCAX ARYE RACY AMCI ABGI RICO ATAQ GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
3172 North Rainbow Boulevard, Suite 1278, Las Vegas, NV, USA, 89108
Website
https://www.researchalliancecorp.com
Research Alliance Corp II is a blank check company.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Peter Kolchinsky director, officer: Chief Executive Officer 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Stephen J Hoffman director C/O SKYLINE VENTURES, 525 UNIVERSITY AVE., SUITE 1350, PALO ALTO CA 94301
Thomas Leggett director C/O AXCELLA HEALTH INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Matthew Hammond director, officer: Chief Investment Officer 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Research Alliance Holdings Ii Llc 10 percent owner 200 BERKELEY STREET 18TH FLOOR, BOSTON MA 02116
Theresa Cameron director, 10 percent owner, officer: Chief Financial Officer C/O THERAPEUTICS ACQUISITION CORP., 200 BERKELEY STREET. 18TH F L, BOSTON MA 02116
Clive Patience director C/O RESEARCH ALLIANCE CORP. II, 3172 NORTH RAINBOW BLVD. SUITE 1278, LAS VEGAS NV 89108

Research Alliance II (Research Alliance II) Headlines

From GuruFocus

Research Alliance Corp. II Will Redeem Public Shares

By Business Wire Business Wire • 11-28-2022

POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility

By Business Wire Business Wire • 04-28-2021